Trial Profile
Optimized Administration of Prothrombin Complex Concentrate (PCC) vs. Standard Transfusion During/After Heart Transplantation - OPSTAHT
Status:
Recruiting
Phase of Trial:
Phase III
Latest Information Update: 10 Jan 2024
Price :
$35
*
At a glance
- Drugs Prothrombin complex concentrate (Primary) ; Plasma
- Indications Haemorrhage
- Focus Therapeutic Use
- Acronyms OPSTAHT
- 04 Jan 2024 Planned End Date changed from 1 Dec 2023 to 1 Oct 2024.
- 04 Jan 2024 Planned primary completion date changed from 1 Oct 2023 to 1 Oct 2024.
- 09 Nov 2022 Planned End Date changed from 1 Dec 2022 to 1 Dec 2023.